LIVE PLATFORM

Introducing Brokers

Grow with the PAMM PLATFORM Introducing Broker Program

Refer qualified investors and fund managers and earn commissions according to your assigned partnership terms.

01

How the IB program works

Apply, pass review and KYC, receive your IB ID and referral link, refer clients, and earn commission on eligible activity under your assigned plan.

02

Who can join

Educators, community owners, money managers' networks, regional partners and businesses that meet the operating broker's eligibility and country rules.

03

Commission models

CPA, per-lot, spread share, revenue share, PAMM performance/management fee share and hybrid plans — all configured by the operating broker.

04

Referral tracking

Unique referral code, campaign links with UTM parameters, click → registration → verification → deposit → investment funnel.

05

Sub-IB

Optional, limited-depth sub-IB networks with configurable override commission. Unlimited pyramid structures are not supported.

06

Reporting

Referral, client-activity, commission, payout and monthly statements with CSV export. Referred client data is masked by privacy policy.

07

Marketing tools

Referral link, QR code and campaign link builder. Approved creative assets are provided by the broker when available.

08

Payouts

Commission becomes available after a configurable hold period. Payout requests require two-factor authentication and are reviewed.

09

Compliance

Permitted countries, marketing rules, disclosures and agreements are set by the licensed broker. Self-referral and suspicious patterns are reviewed.

Commission calculator

Illustrative estimate only. Not a promise of earnings — actual terms come from your assigned plan.

$500.00

Commissions are not guaranteed. Eligibility, rates and payouts depend on the operating broker's terms, local regulations and client activity.

Risk warning. Investing in PAMM accounts involves trading leveraged instruments. You can lose part or all of your capital. Past performance does not guarantee future results. Read the full risk disclosure.